Bianca Santomasso

17.5k total citations · 2 hit papers
46 papers, 3.7k citations indexed

About

Bianca Santomasso is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Bianca Santomasso has authored 46 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Bianca Santomasso's work include CAR-T cell therapy research (27 papers), Brain Metastases and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bianca Santomasso is often cited by papers focused on CAR-T cell therapy research (27 papers), Brain Metastases and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bianca Santomasso collaborates with scholars based in United States, Italy and Spain. Bianca Santomasso's co-authors include Elena Mead, Craig S. Sauter, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain, Brigitte Sénéchal, Xiuyan Wang, Jae H. Park, Yongzeng Wang and Marco L. Davila and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Bianca Santomasso

43 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

2018 1.8k citations Jae H. Park, Isabelle Rivière et al. profile →
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1998 677 citations Carlos Bais, Bianca Santomasso et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bianca Santomasso United States	19	3.2k	779	764	683	653	46	3.7k
Chrystal U. Louis United States	20	3.5k 1.1×	1.1k 1.4×	1.3k 1.7×	1.1k 1.6×	801 1.2×	56	4.6k
Daniel Li United States	15	2.8k 0.9×	748 1.0×	614 0.8×	814 1.2×	863 1.3×	24	3.3k
Daniel J. Landsburg United States	23	2.4k 0.8×	722 0.9×	721 0.9×	716 1.0×	513 0.8×	136	3.3k
Bambi Grilley United States	21	3.7k 1.2×	1.2k 1.6×	1.5k 1.9×	1.5k 2.2×	920 1.4×	69	4.4k
Antonio Di Stasi United States	16	2.2k 0.7×	887 1.1×	954 1.2×	916 1.3×	648 1.0×	42	2.8k
Jennifer N. Brudno United States	19	2.9k 0.9×	1.0k 1.3×	928 1.2×	730 1.1×	877 1.3×	28	3.5k
Theodoros Giavridis United States	7	3.2k 1.0×	1.6k 2.1×	1.4k 1.8×	1.0k 1.5×	1.1k 1.8×	7	4.4k
Matthew J. Frigault United States	25	2.9k 0.9×	885 1.1×	851 1.1×	717 1.0×	951 1.5×	131	3.4k
Meng-Fen Wu United States	24	1.9k 0.6×	679 0.9×	642 0.8×	537 0.8×	336 0.5×	43	2.6k
Susanna Harju-Baker United States	13	1.6k 0.5×	432 0.6×	398 0.5×	420 0.6×	525 0.8×	19	2.1k

Countries citing papers authored by Bianca Santomasso

Since Specialization

Citations

This map shows the geographic impact of Bianca Santomasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca Santomasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca Santomasso more than expected).

Fields of papers citing papers by Bianca Santomasso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bianca Santomasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca Santomasso. The network helps show where Bianca Santomasso may publish in the future.

Co-authorship network of co-authors of Bianca Santomasso

This figure shows the co-authorship network connecting the top 25 collaborators of Bianca Santomasso. A scholar is included among the top collaborators of Bianca Santomasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bianca Santomasso. Bianca Santomasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Nielsen, Dorte, et al.. (2025). Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis. Cancer Treatment Reviews. 140. 103011–103011.

2.

Deschênes‐Simard, Xavier, Bianca Santomasso, & Parastoo B. Dahi. (2024). Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy. Blood. 144(20). 2083–2094. 12 indexed citations

3.

Deschênes‐Simard, Xavier, Martina Pennisi, Miguel‐Angel Perales, et al.. (2024). Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma. Leukemia & lymphoma. 66(3). 535–540.

4.

Reiner, Anne S., Jae H. Park, Martina Pennisi, et al.. (2024). EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy. Scientific Reports. 14(1). 29090–29090. 1 indexed citations

5.

Santomasso, Bianca, Juliane Gust, & Fabiana Perna. (2023). How I treat unique and difficult to manage cases of CAR T-cell therapy associated neurotoxicity. Blood. 141(20). 2443–2451. 37 indexed citations

6.

Park, Jae H., Karthik Nath, Sean M. Devlin, et al.. (2023). CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results. Nature Medicine. 29(7). 1710–1717. 99 indexed citations

7.

Gewirtz, Alexandra N., Sham Mailankody, Saad Z. Usmani, & Bianca Santomasso. (2023). IMMU-45. REVERSIBLE PARKINSONISM AFTER BCMA-DIRECTED CAR T CELL ADMINISTRATION. Neuro-Oncology. 25(Supplement_5). v152–v152. 1 indexed citations

8.

Goldman, Adam, Emanuel Raschi, Joab Chapman, et al.. (2022). Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. Blood. 141(6). 673–677. 8 indexed citations

9.

Moss, Nelson S., Umberto Tosi, Bianca Santomasso, Kathryn Beal, & Shanu Modi. (2022). Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan. CNS Oncology. 11(3). CNS90–CNS90. 5 indexed citations

10.

Luo, Jia, Jason Beattie, Hira Rizvi, et al.. (2021). Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events. Journal of Thoracic Oncology. 16(10). 1759–1764. 74 indexed citations

11.

Francis, Jasmine H., Bianca Santomasso, David H. Abramson, et al.. (2020). Immune Checkpoint Inhibitor-Associated Optic Neuritis. Ophthalmology. 127(11). 1585–1589. 33 indexed citations

12.

Wudhikarn, Kitsada, M. Lia Palomba, Martina Pennisi, et al.. (2020). Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma. Blood Cancer Journal. 10(8). 79–79. 161 indexed citations

13.

Smith, Eric L., Sham Mailankody, Mette Stæhr, et al.. (2019). BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy. Cancer Immunology Research. 7(7). 1047–1053. 67 indexed citations

14.

Chen, Xi, et al.. (2019). Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy. Clinical Neurophysiology. 130(8). 1440–1445. 45 indexed citations

15.

Santomasso, Bianca, Jae Hong Park, Isabelle Rivière, et al.. (2018). Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL) (S23.008). Neurology. 90(15_supplement). 3 indexed citations

16.

Blachère, Nathalie E., Dana E. Orange, Emily C. Gantman, et al.. (2017). T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy. JCI Insight. 2(21). 2 indexed citations

17.

Park, Jae Hong, Isabelle Rivière, Xiuyan Wang, et al.. (2017). Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy.. Journal of Clinical Oncology. 35(15_suppl). 7008–7008. 13 indexed citations

18.

Blachère, Nathalie E., et al.. (2009). Tolerance to the Neuron-Specific Paraneoplastic HuD Antigen. PLoS ONE. 4(6). e5739–e5739. 21 indexed citations

19.

Bais, Carlos, Bianca Santomasso, Omar A. Coso, et al.. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 392(6672). 210–210. 27 indexed citations

20.

Bais, Carlos, Bianca Santomasso, Omar A. Coso, et al.. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391(6662). 86–89. 677 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact